Morgan Stanley

13F Holdings History for Royalty Pharma plc - Class A ordinary shares, par value US$0.0001 per share (RPRX)

Symbol: RPRX on Nasdaq
Investment type: Equity / Class A ordinary shares, par value US$0.0001 per share
Latest Disclosed Ownership: 38.9M shares
Security Ownership: 9.2%

Shares, Excluding Options vs Price

Value, Excluding Options

Morgan Stanley ownership in Royalty Pharma plc Class A ordinary shares, par value US$0.0001 per share (RPRX)

2025-08-05 - Morgan Stanley has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 38.9M shares of Royalty Pharma plc Class A ordinary shares, par value US$0.0001 per share (RPRX). This represents 9.2% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Morgan Stanley	9.2%		$1.29B	38.9M			$33.15	13G/A	6/30/2025	5 Aug 2025 11:56:29

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.11%	+0.01%	$1.68B	46.6M	+5,574,272	+13.6%	$36.03	Q2 2025
3/31/2025	0.09%	+0%	$1.28B	41M	+1,497,061		$31.13	Q1 2025
3/31/2025			$49.00	1			$49.00^*	Q1 2025
12/31/2024	0.07%	0%	$1.01B	39.5M	-1,545,392		$25.51	Q4 2024
9/30/2024	0.08%	-0.01%	$1.16B	41.1M	-3,055,284		$28.29	Q3 2024
9/30/2024			$55.00	1			$55.00^*	Q3 2024
6/30/2024	0.09%	0%	$1.16B	44.1M	-84,439		$26.37	Q2 2024
3/31/2024	0.11%		$1.34B	44.2M			$30.37	Q1 2024
3/31/2024	0.11%		$115	3			$38.33^*	Q1 2024
12/31/2023	0.11%		$81.00	2			$40.50^*	Q4 2023
12/31/2023	0.11%		$1.3B	46.4M			$28.09	Q4 2023
9/30/2023	0.13%	+0%	$1.31B	48.1M	+702,754	+1.48%	$27.14^*	Q3 2023
6/30/2023	0.14%	+0%	$1.46B	47.4M	+79,403	+0.17%	$30.74^*	Q2 2023
3/31/2023	0.18%	-0.01%	$1.71B	47.4M	-1,895,574	-3.85%	$36.03	Q1 2023
12/31/2022	0.22%	0%	$1.95B	49.2M	-940,129	-1.87%	$39.52	Q4 2022
9/30/2022	0.28%	-0.01%	$2.02B	50.2M	-1,357,010	-2.63%	$40.18	Q3 2022
6/30/2022	0.28%	-0.01%	$2.17B	51.5M	-1,998,617	-3.73%	$42.04	Q2 2022
3/31/2022	0.28%	-0.01%	$2.09B	53.5M	-2,688,902	-4.78%	$38.96	Q1 2022
12/31/2021	0.28%	-0.01%	$2.24B	56.2M	-1,074,621	-1.88%	$39.85	Q4 2021
9/30/2021	0.28%	+0.03%	$2.07B	57.3M	+6,511,270	+12.8%	$36.14	Q3 2021
6/30/2021	0.27%	+0.02%	$2.08B	50.8M	+2,675,804	+5.56%	$40.99	Q2 2021
3/31/2021	0.31%	+0.17%	$2.1B	48.1M	+24,320,156	+102%	$43.62	Q1 2021
12/31/2020	0.18%	+0.11%	$1.19B	23.8M	+14,431,463	+154%	$50.05	Q4 2020
9/30/2020	0.08%	+0.03%	$394M	9.37M	+3,161,432	+50.9%	$42.07	Q3 2020
6/30/2020	0.07%	+0.07%	$301M	6.21M	+6,205,186	NEW	$48.55	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.